Key facts
- This page summarizes Andrew Smith-Van Vurst's Form 4 filing for BioStem Technologies, Inc. (BSEM).
- 2 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 09 Oct 2026, 16:30.
Andrew Smith-Van Vurst - 07 Oct 2026 Form 4 Insider Report for BioStem Technologies, Inc. (BSEM)
- Reporting relationship
- Chief Operating Officer, Director, 10%+ Owner
- Issuer ticker
- BSEM
- Reported as of
- 07 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Oct 2026, 16:30:06 UTC
- Prior SEC filing
- 17 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Katherine Gorrell, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Andrew Smith-Van Vurst filed Form 4 for BioStem Technologies, Inc. (BSEM) on 09 Oct 2026.
Change
- Previous filing in this sequence was filed on 17 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002147206
Primary reporting owner
SMITH-VAN VURST ANDREW
- Relationship
- Chief Operating Officer, Director, 10%+ Owner
- Address
- C/O BIOSTEM TECHNOLOGIES, INC., 2836 CENTER PORT CIRCLE, POMPANO BEACH
- Signature
- /s/ Katherine Gorrell, Attorney-in-Fact
- Signature date
- 09 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSEM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +250,000
- Change %
- +16%
- Price
- $2.00*
- Shares after
- 1,789,809
- Date
- 07 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BSEM
transaction
Derivative
Options (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -250,000
- Change %
- -11%
- Price
- $0.000000*
- Shares after
- 2,000,000
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- $2.00
- Footnotes
- F4
BSEM
holding
Derivative
Series A-1 Convertible Preferred Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100
- Exercise price
- Footnotes
- F1, F2, F3
BSEM
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 114,314
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 114,314
- Exercise price
- $10.05
- Footnotes
- F5
BSEM
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 23,246
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,246
- Exercise price
- $10.05
- Footnotes
- F6
BSEM
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 253,304
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 253,304
- Exercise price
- $5.50
- Footnotes
- F7
BSEM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 30,487
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,487
- Exercise price
- Footnotes
- F8, F9
BSEM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 57,442
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 57,442
- Exercise price
- Footnotes
- F8, F10
BSEM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 209,091
- Date
- 07 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 209,091
- Exercise price
- Footnotes
- F8, F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 11 footnotes
Footnote F1
The Series A-1 Convertible Preferred Shares are convertible in whole into shares of the Issuer's Common Stock on a one-to-one basis at the option of a majority of the holders of Series A-1 Convertible Preferred Shares.
Footnote F2
The Series A-1 Convertible Preferred Shares have no expiration date.
Footnote F3
Due to an administrative error, the Series A-1 Convertible Preferred Shares were inadvertently omitted from the Reporting Person's Form 3 filed on August 14, 2026.
Footnote F4
These options are fully vested and exercisable.
Footnote F5
These options vest according to the following schedule: 33% vested on March 17, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
Footnote F6
These options vest according to the following schedule: 33% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
Footnote F7
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
Footnote F8
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F9
These restricted stock units will vest in equal quarterly installments over three years from the grant date (September 15, 2024).
Footnote F10
These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
Footnote F11
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.